Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qianlie Anshuan
- Development stage
- Unknown
- Lead developer
- Livzon Pharmaceutical
- Administration
- Rectal
01
Overview
Qianlie Anshuan is a Traditional Chinese Medicine (TCM) rectal suppository developed and manufactured by Lizhu Pharmaceutical Group. It is primarily indicated for the treatment of chronic prostatitis and benign prostatic hyperplasia (BPH), particularly for patients presenting with damp-heat and blood stasis syndromes according to TCM theory. The formulation is composed of several herbal extracts, including *Phellodendri Chinensis Cortex* (Huangbai), *Anemarrhenae Rhizoma* (Zhimu), *Rhei Radix et Rhizoma* (Dahuang), *Notoginseng Radix et Rhizoma* (Sanqi), *Polygonum cuspidatum* (Huzhang), *Gleditsiae Spina* (Zaojiaoci), and *Verbena officinalis* (Mabiancao). Administered rectally, the drug allows for local absorption through the rectal mucosa, facilitating direct action on the adjacent prostate gland. Its therapeutic mechanisms involve clearing heat, detoxifying, promoting blood circulation, and relieving pain, which collectively help to reduce prostatic congestion, alleviate inflammation, and improve urinary symptoms.
- Brand names
- Qianlie Anshuan
- Other names
- Qianliean SuppositoryQianliean Shuan前列安栓
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL8 (C-X-C Motif Chemokine Ligand 8)IL-6 (Interleukin 6)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on Qianlie Anshuan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qianlie Anshuan.